Completed
See Result

Research Commercialisation Project from Publicly Funded Research

Important dates

14 Aug 2019

Date call is made active

25 Sep 2019

Application submission deadline

02 Jan 2020

Earliest permitted project start

01 May 2020

Latest permitted project start

30 Apr 2023

Latest permitted project completion

Important dates

Purpose

Commercialisation Projects are to help to increase commercial utilisation and value creation based on the results of publicly funded research in Norway.

The purpose is to facilitate the development of high-potential results from publicly funded research towards future commercialisation and to clarify questions relating to commercial, conceptual and technological aspects.

This call is open to project proposals within all thematic areas.

About the results of the application assessment process

Total amount sought
NOK 368 000 000
Amount awarded
NOK 135 000 000
Total number of applications
66
Number of approved applications
23
Approved applications
Project no.
Organization
Project title
Subject
Sought
Published
310160NORGES TEKNISK-NATURVITENSKAPELIGE UNIVERSITET NTNUPRESORT: Platform for clinical decision support for precision therapyN/AN/A22.06.2021
310107OSLO UNIVERSITETSSYKEHUS HFA Biologic Therapeutic for Pulmonary Fibrosis.N/AN/A22.06.2021
310097UNIVERSITETET I TROMSØ - NORGES ARKTISKE UNIVERSITET UIT CAMPUS TROMSØTackling drug resistant acute myeloid leukaemia with the next-generation FLT3 inhibitorN/AN/A22.06.2021
310054UNIVERSITETET I OSLO, Institutt for Klinisk MedisinNew drug for treatment of multiple myeloma patientsN/AN/A22.06.2021
310045UNIVERSITETET I OSLONew therapies for Immune Thrombocytopenia (ITP) - targeting antibody secreting cellsN/AN/A22.06.2021
309894VESTLANDETS INNOVASJONSSELSKAP ASPRESTIIS - Predicting Stress in SalmonN/AN/A22.06.2021
309871SIMULA RESEARCH LABORATORY ASIdentiPhy: In Silico Diagnostics Enabling Novel Translation of Microphysiological SystemsN/AN/A22.06.2021
309860MOBAI ASMobai Commercialisation ProjectN/AN/A22.06.2021
309798SINTEF ASLogic GroutingN/AN/A22.06.2021
309785UNIVERSITETET I TROMSØ - NORGES ARKTISKE UNIVERSITETMicroRNAs for risk assessment and treatment of venous thromboembolismN/AN/A22.06.2021
309778NTNU TECHNOLOGY TRANSFER ASAiBA - Author Behavioural Analysis, to keep children safe onlineN/AN/A22.06.2021
309761UNIVERSITETET I BERGENDevelopment of a novel targeted therapy against Triple-Negative Breast CancerN/AN/A22.06.2021
309610OSLO UNIVERSITETSSYKEHUS HFIn silico pathology - from bench to bedsideN/AN/A22.06.2021
309564SINTEF TTO ASMicroSounder: a new MEMS component for airborne ultrasound applicationsN/AN/A22.06.2021
309555SINTEF TTO ASENPERITO: Effective Nanoparticles for Treatment of Peritoneal MetastasesN/AN/A22.06.2021
309513NTNU TECHNOLOGY TRANSFER ASViSiBeam - the Vital Signs Birth MonitorN/AN/A22.06.2021
309495Klinisk institutt 1Eye drops for Hereditary Corneal Vascularization treatmentN/AN/A22.06.2021
309481Sintef ASA novel antimicrobial macrolide – preparation for the future combat of multi drug resistant bacteriaN/AN/A22.06.2021
309415INVEN2 ASDNA vaccine against pandemic influenzaN/AN/A22.06.2021
309407Ard Innovation ASEco-friendly Biostimulant for Potato Cyst Nematode Disinfection - CystLabN/AN/A22.06.2021
309374LITERATE ASLiterate - Commercialization of dyslexia screening tests.N/AN/A22.06.2021
309258ARD INNOVATION ASDevelopment and testing of a novel mixing technology - IsDeCaN/AN/A22.06.2021
309249ARD INNOVATION ASPolySorb - verification, industrialization and commercialization.N/AN/A22.06.2021

Messages at time of print 1 October 2022, 03:54 CEST

No global messages displayed at time of print.